Qube Research & Technologies LTD Global Blood Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $8.05 Million - $16.9 Million	248,408 New	248,408 $16.9 Million
Q3 2021 Nov 12, 2021	SELL	$25.48 - $37.34 $520,760 - $763,154	-20,438 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$32.46 - $43.42 $663,417 - $887,417	20,438 New	20,438 $716,000
Q3 2020 Nov 12, 2020	SELL	$52.76 - $74.49 $2.8 Million - $3.96 Million	-53,161 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $2.59 Million - $4.35 Million	53,161 New	53,161 $3.36 Million
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $237,470 - $496,342	-5,692 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$45.7 - $81.86 $260,124 - $465,947	5,692 New	5,692 $452,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.